SEC Form 4 · accession 0001437749-26-025661
Imunon, Inc. · IMNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Eylward
Officer — General Counsel and Corp Sec
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000749647
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2026 | A | 2,541 | $1.59 | A | 5,437 | D | |
| Common StockF2 | Aug 3, 2026 | S | 2,541 | $1.5651 | D | 2,896 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Stock granted in lieu of cash for portion of base salary
- F2Reflects a weighted average sale price of $1.5651 per share, at prices ranging from $1.56 to $1.575 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.